# Xometry share price today (Xometry, Inc., XMTR)

> Xometry, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. XMTR · Industrials · Industrial Distribution · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/xmtr

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $111.29 (+128.6% in a year)
- Revenue (Jun 2026): $229 M (+41.1% on a year ago)
- Profit (Jun 2026): −$5.3 M
- Operating margin: −2.4% (+3.9 points on a year ago)
- ROE: −22%, FY25
- ROIC: −1.5%, against a 11.0% cost of capital: −12.5 points

Biggest thing to watch: the price has already been rising for 28 weeks, so timing is the risk more than the business. ## What is the Xometry share price today? Xometry, Inc.'s share price was $111.29 at the close on 3 November 2026. It has been rising for 28 weeks. That is 45.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between $37 and $111, and at that close it was at the high of that range. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 3 weeks in a row. Over the last 5.3 years the share price moved +60% while the S&P 500 moved +74%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Xometry pay? Xometry, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Xometry on? Xometry is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Xometry profitable? Xometry, Inc. posted a net loss of $5.3 M in the Jun 2026 quarter. The full FY25 year was a loss of $61.7 M. That loss is 2.3% of the quarter's revenue. The same quarter a year earlier lost $26.4 M. 12 of the last 12 reported quarters were loss-making. ## How much revenue does Xometry make, and is it growing? Xometry, Inc. reported $229 M of revenue in the Jun 2026 quarter, +41.1% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 33.2% a year on average. The last full year, FY25, came in at $687 M. The last four reported quarters add to $808 M. FY25 revenue was $687 M, +25.9% on the year before. Recent pace: the last four quarters grew +33.5% on average, against 33.2% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +33.7%, against +26.8% a year over the last 8 quarters (accelerating). ## How much of every $100 of sales does Xometry keep? Xometry, Inc.'s operating margin was −2.4% in the Jun 2026 quarter, 3.9 percentage points higher than the same quarter a year ago. Across 5 years it has been between −26.9% and −6.4%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +3.9 percentage points on the year while gross margin changed −2.1 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Xometry's profit turning into cash? Xometry, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 it brought in $6.1 M of operating cash against −$61.7 M of profit. After $30.2 M of spending on assets, free cash was −$24.1 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Xometry's cash go? Xometry, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $66.8 M on assets over the last 3 years. Averaged over those years that is 3.2% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $66.8 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Xometry's P/E ratio, and how does it compare with its own history? Xometry, Inc. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Xometry, Inc. at 9.3× its FY25 revenue of $687 M. The P/E comes back here once profit turns positive. ## Is the Xometry business getting better or worse? Xometry, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Xometry earn on its capital? Xometry, Inc. earned a ROE of −22% in FY25. Its return on capital used (ROIC) is 12.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −9.0% net margin and 0.98× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −9.0% net margin × 0.98× asset turnover × 2.54× leverage (assets divided by equity) ≈ −22.4% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: −1.5% − 11.0% = −12.5 percentage points. The 11.0% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Xometry have too much debt? Xometry, Inc. has total debt of $340 M against shareholder equity of $596 M as of Jun 2026, so its debt is 0.57× its equity. Year by year, that ratio went from 0.05 in FY21 to 1.23 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Xometry shareholding pattern? 7.3% of Xometry, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.1 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Xometry from balance-sheet trouble? For Xometry, Inc., the Z-score is 4.40. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 4.40 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Xometry rank in its industry? 56.9 out of 100, rank 6 of 20 in Industrial Distribution, with 61% of the evidence available. Xometry, Inc. scores 56.9 out of 100 against the 20 companies it is compared with in Industrial Distribution, ranking 6. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 25.2 + 3 + 10 + 18.7 = 56.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Xometry compared with? Xometry ranks 6 of 20 Industrial Distribution companies on the 4-Factor Sector Score, with 56.9 out of 100. 1. [Global Industrial Company](https://www.sectoralpha.in/us/stocks/gic) GIC · leader · Most evidence points up · 81% evidence 70.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.4/35 · Revenue 8.5% · Profit 29.9% · Operating margin change -2 points · 83% evidence Capital efficiency 17.4/25 · ROCE 22.1% · Operating margin 7.3% · 76% evidence Valuation 15.8/20 · P/E 14.9× · PEG 0.49 · 65% evidence Relative strength 18.6/20 · Lead over its industry 16.2% · Lead over S&P 500 23.8% · 1 year 61.7% · 100% evidence · 12 of 12 weeks ahead Exact sum: 18.4 + 17.4 + 15.8 + 18.6 = 70.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Fastenal Company](https://www.sectoralpha.in/us/stocks/fast) FAST · losing its lead · Evidence leans up · 85% evidence 64.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.6/35 · Revenue 13.5% · Profit 15.7% · Operating margin change 0.8 points · 95% evidence Capital efficiency 21.4/25 · ROCE 41.2% · Operating margin 21.5% · 76% evidence Valuation 5.8/20 · P/E 40.1× · PEG 2.68 · 65% evidence Relative strength 12.0/20 · Lead over its industry 1.2% · Lead over S&P 500 7.9% · 1 year 28.1% · 100% evidence · 6 of 12 weeks ahead Exact sum: 25.6 + 21.4 + 5.8 + 12 = 64.8 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Ferguson Enterprises Inc.](https://www.sectoralpha.in/us/stocks/ferg) FERG · basing · Evidence leans up · 81% evidence 59.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.2/35 · Revenue 5.1% · Profit 23.7% · Operating margin change -0.1 points · 83% evidence Capital efficiency 18.1/25 · ROCE 22.1% · Operating margin 10.2% · 76% evidence Valuation 14.4/20 · P/E 22.6× · PEG 0.86 · 65% evidence Relative strength 4.6/20 · Lead over its industry -9% · Lead over S&P 500 -3.1% · 1 year -3.1% · 100% evidence · 1 of 12 weeks ahead Exact sum: 22.2 + 18.1 + 14.4 + 4.6 = 59.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [W.W. Grainger, Inc.](https://www.sectoralpha.in/us/stocks/gww) GWW · turning · Evidence leans up · 81% evidence 58.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.4/35 · Revenue 7.8% · Profit -2.7% · Operating margin change 1.2 points · 83% evidence Capital efficiency 20.5/25 · ROCE 39.6% · Operating margin 16.1% · 76% evidence Valuation 4.7/20 · P/E 34.3× · PEG 3.23 · 65% evidence Relative strength 15.9/20 · Lead over its industry 4.7% · Lead over S&P 500 11.7% · 1 year 46.4% · 100% evidence · 1 of 12 weeks ahead Exact sum: 17.4 + 20.5 + 4.7 + 15.9 = 58.5 · What this means: Relative strength against the index is 11.7%, and revenue and profit growth are weak. 5. [MSC Industrial Direct Co., Inc.](https://www.sectoralpha.in/us/stocks/msm) MSM · turning · Evidence leans up · 85% evidence 57.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue 6.4% · Profit 11% · Operating margin change 1.7 points · 95% evidence Capital efficiency 17.2/25 · ROCE 21.1% · Operating margin 10.9% · 76% evidence Valuation 7.4/20 · P/E 29.9× · PEG 2.48 · 65% evidence Relative strength 11.0/20 · Lead over its industry 2.6% · Lead over S&P 500 9.4% · 1 year 36.7% · 100% evidence · 2 of 12 weeks ahead Exact sum: 22.3 + 17.2 + 7.4 + 11 = 57.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. Xometry, Inc. this page XMTR · turning · Evidence leans up · 61% evidence 56.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.2/35 · Revenue 33.4% · Profit n/a · Operating margin change 3.9 points · 62% evidence Capital efficiency 3.0/25 · ROCE -3.6% · Operating margin -2.4% · 76% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 18.7/20 · Lead over its industry 36.3% · Lead over S&P 500 45.6% · 1 year 71.7% · 100% evidence · 5 of 12 weeks ahead Exact sum: 25.2 + 3 + 10 + 18.7 = 56.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [EVI Industries, Inc.](https://www.sectoralpha.in/us/stocks/evi) EVI · breaking out · Evidence leans up · 81% evidence 51.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 14.1% · Profit 0% · Operating margin change 0.6 points · 83% evidence Capital efficiency 8.1/25 · ROCE 7.2% · Operating margin 4.6% · 76% evidence Valuation 11.7/20 · P/E 29× · PEG 1.34 · 65% evidence Relative strength 13.7/20 · Lead over its industry 0.5% · Lead over S&P 500 7.1% · 1 year -20.2% · 100% evidence · 8 of 12 weeks ahead Exact sum: 18.2 + 8.1 + 11.7 + 13.7 = 51.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [WESCO International, Inc.](https://www.sectoralpha.in/us/stocks/wcc) WCC · losing its lead · Evidence leans up · 81% evidence 50.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 12.5% · Profit 12.9% · Operating margin change 0.5 points · 83% evidence Capital efficiency 11.6/25 · ROCE 11.1% · Operating margin 6.1% · 76% evidence Valuation 10.3/20 · P/E 23.5× · PEG 1.77 · 65% evidence Relative strength 7.7/20 · Lead over its industry -0.1% · Lead over S&P 500 6.5% · 1 year 37.7% · 100% evidence · 2 of 12 weeks ahead Exact sum: 20.8 + 11.6 + 10.3 + 7.7 = 50.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Titan Machinery Inc.](https://www.sectoralpha.in/us/stocks/titn) TITN · breaking out · Evidence leans down · 67% evidence 49.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.4/35 · Revenue -10.7% · Profit n/a · Operating margin change -0.5 points · 71% evidence Capital efficiency 4.5/25 · ROCE -0.6% · Operating margin -0.3% · 76% evidence Valuation 11.2/20 · P/E -6.1× · PEG n/a · 15% evidence Relative strength 18.8/20 · Lead over its industry 7.6% · Lead over S&P 500 14.6% · 1 year 47.1% · 100% evidence · 11 of 12 weeks ahead Exact sum: 15.4 + 4.5 + 11.2 + 18.8 = 49.9 · What this means: Relative strength against the index is 14.6%, and revenue and profit growth are weak. 10. [SiteOne Landscape Supply, Inc.](https://www.sectoralpha.in/us/stocks/site) SITE · turning · Evidence leans down · 81% evidence 49.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.4/35 · Revenue 3.3% · Profit 30.6% · Operating margin change 0.1 points · 83% evidence Capital efficiency 10.2/25 · ROCE 9.4% · Operating margin 12.9% · 76% evidence Valuation 12.7/20 · P/E 31.7× · PEG 0.96 · 65% evidence Relative strength 6.9/20 · Lead over its industry -16.8% · Lead over S&P 500 -11.4% · 1 year -9.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 19.4 + 10.2 + 12.7 + 6.9 = 49.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Applied Industrial Technologies, Inc.](https://www.sectoralpha.in/us/stocks/ait) AIT · quiet · Evidence leans down · 81% evidence 48.4 out of 100 Growth Capital Valuation Relative
12. [DXP Enterprises, Inc.](https://www.sectoralpha.in/us/stocks/dxpe) DXPE · losing its lead · Evidence leans down · 81% evidence 47.4 out of 100 Growth Capital Valuation Relative
13. [Pool Corporation](https://www.sectoralpha.in/us/stocks/pool) POOL · turning · Evidence leans down · 75% evidence 46.5 out of 100 Growth Capital Valuation Relative
14. [Distribution Solutions Group, Inc.](https://www.sectoralpha.in/us/stocks/dsgr) DSGR · losing its lead · Evidence leans down · 71% evidence 45.4 out of 100 Growth Capital Valuation Relative
15. [BlueLinx Holdings Inc.](https://www.sectoralpha.in/us/stocks/bxc) BXC · losing its lead · Too little evidence to rank firmly · 58% evidence 43.7 out of 100 Growth Capital Valuation Relative
16. [Core & Main, Inc.](https://www.sectoralpha.in/us/stocks/cnm) CNM · basing · Evidence leans down · 85% evidence 40.8 out of 100 Growth Capital Valuation Relative
17. [DNOW Inc.](https://www.sectoralpha.in/us/stocks/dnow) DNOW · losing its lead · Evidence leans down · 71% evidence 38.4 out of 100 Growth Capital Valuation Relative
18. [Resideo Technologies, Inc.](https://www.sectoralpha.in/us/stocks/rezi) REZI · basing · Too little evidence to rank firmly · 58% evidence 36.0 out of 100 Growth Capital Valuation Relative
19. Watsco, Inc. WSO-B · Most evidence points down · 61% evidence 34.3 out of 100 Growth Capital Valuation Relative
20. [QXO, Inc.](https://www.sectoralpha.in/us/stocks/qxo) QXO · basing · Most evidence points down · 64% evidence 32.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Industrial Distribution](https://www.sectoralpha.in/us/sectors/industrial-distribution), all 20 compared on one page. ## Which companies are close to Xometry in size? Xometry is the 11th largest of 20 Industrial Distribution companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Core & Main, Inc., Pool Corporation and MSC Industrial Direct Co., Inc. Just below it: SiteOne Landscape Supply, Inc., Resideo Technologies, Inc. and DNOW Inc. ### Industrial Distribution companies close in size

1. [Core & Main, Inc.](https://www.sectoralpha.in/us/stocks/cnm) $8.5 billion
2. [Pool Corporation](https://www.sectoralpha.in/us/stocks/pool) $7.4 billion
3. [MSC Industrial Direct Co., Inc.](https://www.sectoralpha.in/us/stocks/msm) $6.7 billion
4. Xometry, Inc. $6.4 billion
5. [SiteOne Landscape Supply, Inc.](https://www.sectoralpha.in/us/stocks/site) $4.8 billion
6. [Resideo Technologies, Inc.](https://www.sectoralpha.in/us/stocks/rezi) $2.9 billion
7. [DNOW Inc.](https://www.sectoralpha.in/us/stocks/dnow) $2.9 billion

[All 20 Industrial Distribution companies, largest first](https://www.sectoralpha.in/us/sectors/industrial-distribution#all-companies)

### Companies close in size in other industries

1. [Maase Inc.](https://www.sectoralpha.in/us/stocks/maas) $5.5 billion · Asset Management
2. [Construction Partners, Inc.](https://www.sectoralpha.in/us/stocks/road) $5.5 billion · Engineering & Construction
3. Xometry, Inc. $5.5 billion
4. [VEON Ltd.](https://www.sectoralpha.in/us/stocks/veon) $5.5 billion · Telecom Services
5. [Nexstar Media Group, Inc.](https://www.sectoralpha.in/us/stocks/nxst) $5.5 billion · Broadcasting

## What else do people ask about Xometry? ### What were Xometry's latest quarterly results? Xometry, Inc. reported revenue of $229 M and a net loss of $5.3 M for the Jun 2026 quarter. Earnings per share were −$0.10. The operating margin was −2.4%, 3.9 percentage points higher than a year earlier (as of 3 November 2026). ### What is Xometry's market cap? Xometry, Inc.'s market capitalisation is $6.4 B at a stock price of $111.29. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Xometry performing? Xometry, Inc.'s share price has been rising for 28 weeks. Over the past 13 weeks it has done better than the S&P 500, for 3 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Xometry's stock price go up? This page does not forecast Xometry, Inc.'s stock price. What it shows instead: the stock price is $111.29, and it has been rising for 28 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Does Xometry have too much debt? Xometry, Inc. has a moderate amount of debt: its debt is 0.56× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is Xometry in its business cycle? Xometry, Inc.'s FY25 operating margin was −6.4%, against a 5-year range of −26.9% to −6.4%: the middle of its own range, neither a peak nor a low. The latest quarter was −2.4%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Xometry story? Biggest thing to watch: the price has already been rising for 28 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Xometry a stock worth studying right now? What the numbers show: Xometry, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.